ADCT7:15 AMADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conferenceadctherapeutics.com
ADCT7:30 AMADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational UpdatesEnrollment • Phase 1adctherapeutics.com
ADCT7:30 AMADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026adctherapeutics.com
ADCT7:15 AMADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination TrialEnrollment • Phase 1Enrollment milestone Tue, Jun 30, 2026adctherapeutics.com
ADCT7:30 AMADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Prioritiesadctherapeutics.com